Published online Jun 14, 2023. doi: 10.3748/wjg.v29.i22.3497
Peer-review started: May 8, 2023
First decision: May 11, 2023
Revised: May 12, 2023
Accepted: May 19, 2023
Article in press: May 19, 2023
Published online: June 14, 2023
Processing time: 30 Days and 4.9 Hours
Achalasia is a rare disorder of the esophageal smooth muscle which cause dysphagia, regurgitation, chest pain and weight loss. In recent years, per-oral endoscopic myotomy (POEM) is emerging as a prefer treatment option for patients achalasia.
Although POEM was proved to be safe and efficacy for adult patients with achalasia, data of POEM in pediatric patients are limited.
To evaluate the safety and long-term efficacy of POEM for pediatric patients with achalasia.
We performed a retrospective cohort study to evaluate the outcome of pediatric patients with achalasia who underwent POEM in comparison to the outcome of all adult patients who underwent POEM within the same period. To evaluate the safety of POEM, we compare the operation-related parameters and complications in the two groups. To evaluate the long-term efficacy of POEM, we compare the body mass index, clinical symptoms, quality of life in pediatric group before and after POEM; and we also compare those outcomes in pediatric group and matched adult group.
The risk of complications relating to POEM was not increased in pediatric patients, and the long-term efficacy of POEM in pediatric patients were similar to the results of adult group.
POEM is safe treatment method and could achieve satisfactory long-term outcomes in pediatric patients.
POEM can be an an effective treatment option for achalasia in pediatric patients.